BioCardia - Stock Price History | BCDA

Historical daily share price chart and data for BioCardia since 2021 adjusted for splits. The latest closing stock price for BioCardia as of October 15, 2021 is 2.93.
  • The all-time high BioCardia stock closing price was 6.70 on December 15, 2020.
  • The BioCardia 52-week high stock price is 8.60, which is 193.5% above the current share price.
  • The BioCardia 52-week low stock price is 1.91, which is 34.8% below the current share price.
  • The average BioCardia stock price for the last 52 weeks is 3.56.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BioCardia Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.2041 3.9038 6.7000 1.9200 3.4600 -5.98%
2019 4.2530 4.9500 6.3000 3.2000 3.6800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.049B $0.000B
BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00